Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Credit: Unsplash/CC0 Public Domain Muscular strength and good physical fitness are linked to a significantly lower risk of death from ...
The science Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour half-life means ...
A targeted cancer therapy from AstraZeneca’s alliance with Daiichi Sankyo is now FDA approved to treat certain cases of advanced ...
Credit: Pixabay/CC0 Public Domain A glass of milk a day could help keep bowel cancer away—or so finds a study ...
A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma, making it the first ...
Skin cancer isn’t just about sun exposure—it’s tied to your overall health. Your metabolism, immune function, and lifestyle habits all ...
Turning to supplements to boost your overall health? This seemingly harmless wellness trend is now being questioned by a cancer ...
For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.